AstraZeneca makes $15B bet on China to expand manufacturing and R&D
AstraZeneca, already one of the leading pharmaceutical companies in China, is extending its reach in the country that’s become a go-to place for drug R&D
AstraZeneca, already one of the leading pharmaceutical companies in China, is extending its reach in the country that’s become a go-to place for drug R&D
Two companies that run on-site health clinics for employers like Google and Amazon are merging as healthcare costs continue to climb. Advanced primary care company
With two positive clinical readouts in the bag, a US approval filing, and another important trial due to report in a couple months, Roche’s breast
The French biotech Abivax was a biotech market standout for 2025. Formation Bio now wants a piece of that success. The privately-held New York pharma
Sanofi says it will be able to spend between €14 billion and €15 billion on M&A deals this year while still being able to meet
Post Content